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INTRODUCTION: 
The  main  objective  of  medicinal  chemistry  is  to  
synthesize  the  compounds  that  show  promising  
activity  as  therapeutic  agents  with lower toxicity.  
Benzoxazoles have been reported to show abroad 
spectrum of biological activity.
1,2
  The  substituted 
benzoxazole  have  been  shown to  exhibit  antitumor,
3
  
antihistaminic,  anti-inflammatory,
4
  herbicidal,  
antiallergic,  antihelmintic,  COX-2inhibitory,
5
  
antifungal,
6
  antibacterial,
7
 antitubercular,
8
  
anticonvulsant,
9
  diarrhea redominant  irritable  bowel  
syndrome,  hypoglycemic,  HIV-1  reverse  transcriptase  
inhibitor  & insecticidal  activities. Insilico modeling of 
different derivatives will be carried out by using software 
such as Chemsketch and Molinspiration. Compounds 
having drug likeness and molecular descriptors, 
resembling those of standard molecules, and which obeys 
the Lipinski Rule of Five will be selected for wet lab 
synthesis. Synthesized compounds were screened for 
anticancer activity. 
MATERIALS AND METHODS: 
All the chemicals and reagents used in the research work 
were of analytical grade or synthetic grade. Melting point 
were determined by melting point apparatus (KHERA) 
and TLC plate were prepared by using silica gel G. Spots 
were visualized by exposure to iodine vapour or UV light. 
IR spectra of the synthesized compounds were recorded 
using FTIR in the    range of 4000-500 cm
-1
 on FTIR-α-zn 
Se ATR -BRUKER Spectrophotometer.
1
HNMR spectra 
were measured with a broker spectrophotomerter (500 
MHz) in CDCl3 using TMS as an internal standard .Mass 
spectra were obtained with LC-MSD Trap-SL 2010 A- 
Shimadzu. 
Synthetic procedure 
(i) Synthesis of 4-Hydroxy-3-nitro-benzoic acid methyl 
ester (p1) 
Mixture  of  12.4ml  of  concentrated  suphuric  acid  and  
concentrated  nitric  acid (1:1)  was  added  to  p- hydroxy 
methyl  benzoate  (10 g, 0.74 mol)  in  a  temperature  0-
10˚c  with continuous  stirring.  Temperature  of  the  
reaction  maintained  between  5 to 15˚c  for  1  hour  and 
then  poured  it  into  crushed  ice  (70g).  From  that  
crude  m-nitro  and  p-hydroxy  methyl benzoate  were  
filtered  off.  Washed   product  was  then  added  to  ice  
cold  methanol  and  stirred  and  filtered  to  remove  the  
trace  of  ortho-isomer  and  other  impurities.  The  purity  
of the  compound  was established  by  single  spot  on  
TLC  plate.  
 (ii)  Synthesis of   3-Amino-4-hydroxy-benzoic acid methyl 
ester (p2) 
In  a  500  ml  three  necked  flat  bottom  flask  equipped  
with  reflux  condenser, Compound p1 (10 g) was 
dissolved in boiling alcohol (50%, 100 ml) and sodium 
ABSTRACT:  
Benzoxazole derivatives display broad spectrum of biological and pharmacological activities. The main objective of the 
present study was to explore newer molecules with potent biological activity like anticancer activity.  Insilico screening was 
done and compound with no violation in Lipinski rule of five and good docking score are selected for wet lab synthesize. 
Benzoxazole derivatives were synthesized and are evaluated for invitro anticancer studies.  Derivatives were synthesized using 
different benzaldehyde and anhydride derivative. The synthesized compounds were then established on the basis of IR, MASS 
and 1H NMR spectral data and screened for anticancer activity on Human breast cancer cell line (MCF-7). The derivative 
showed significant activity on cell line.  
Keywords: Benzoxazole, dihydrophthalazine, anticancer, MTT assay. 
Shitha G et al                                   Journal of Drug Delivery & Therapeutics. 2014; 4(6):122-126  123 
© 2011-14, JDDT. All Rights Reserved                                         ISSN: 2250-1177                                          CODEN (USA): JDDTAO 
dithionate was added to this boiling alcohol solution until 
it becomes almost colorless. Then the alcohol was reduced 
to one third of its volume by distillation and the residual 
liquid was triturated with ice cold water. The resulting 
colorless, shiny product was filtered, washed with cold 
water, dried and recrystallized using methanol as solvent 
(iii)Synthesis of 2-subtituted benzoxazole-5-carboxylic 
acid methyl ester (p3) 
Compound p2 (0.01mol) was heated with an appropriate 
aliphatic acid (formic acid and acetic acid) in excess under 
reflux for 2h. The reaction mixture was cooled and poured 
in crushed ice (100 gm) with stirring. The product thus 
separated was filtered under suction and washed with cold 
water. The products were recrystallized by using methanol 
as a solvent. 
 (iv)Synthesis of 2-substituted benzoxazole-5-carboxylic 
acid hydrazide (p4) 
A mixture of an appropriate 2-subtituted benzoxazole-5-
carboxylic acid methyl ester p3 (0.001 mol) in alcohol (25 
ml) and hydrazine hydrate (99%, 0.015 mol) was heated 
under reflux on water bath for 4 hours. The alcohol was 
reduced to half of its volume and cooled. The product 
separated was filtered and washed with small portions of 
cold alcohol and then with cold water, repeatedly and 
dried. The resultant product was recrystallized using 
methanol as solvent. Using above mentioned procedure 
following two compounds was synthesized. 
(va)Synthesis of 2-[(2-substituted-1, 3-benzoxazol-5-yl) 
carbonyl]-2, 3-dihydrophthalazine-1,4-dione(BCH-b2) 
11.29 mmol of 1, 3-benzoxazole-5-carbohydrazide 
dissolved in 20 mL of acetic acid and 11.29 mmol of 
phthalic anhydride added to the above and content 
refluxed for 8 hrs and the reaction monitored by TLC 
(Methanol: EtOAc/6: 4), quenched in to the ice under 
stirring to get the solid, filtered the solid, washed the solid 
with chilled water and recrystallized from minimum 
amount of methanol to get the white crystalline powder. 
 (vb)Synthesis of N'-[(E)-(4-hydroxy-3-
methoxyphenyl)methylidene] -2-substituted-1, 3-
benzoxazole5-carbohydrazide .(BCH-a1&a2) 
A mixture of compound-p4 (0.01mol) in 50ml ethanol, 4-
Hydroxy-3-methoxy-benzaldehyde (0.01mol) and a few 
drops of acetic acid were refluxed for 2.5 hours at 60˚ C. 
The resulting mixture was poured into ice cold water and 
then it was filtered. Pure compound was obtained from 
DMF and followed a column chromatography. The purity 
was checked by single spot on TLC plate, consistency in 
melting point and Rfvalue. Solvent system used: methanol 
and ethyl acetate-1:1 
 (vc)Synthesis of N'-[(E)-(4-hydroxyphenyl)methylidene] -
2-substituted-1, 3-benzox azole5-carbohydrazide. (BCH-
a3&a4) 
A mixture of compound-p4 (0.01mol) in 50ml ethanol, 4-
Hydroxybenzaldehyde (0.01mol) and a few drops of acetic 
acid were refluxed for 2.5 hours at 60˚ C. The resulting 
mixture was poured into ice cold water and then it was 
filtered. The purity was checked by single spot on TLC 
plate, consistency in melting point and Rf value.
8
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Scheme of synthesis 
 
Pharmacological screening 
The human breast cancer cell line (MCF7) was obtained 
from National Centre for Cell Science (NCCS), Pune and 
grown in Eagles Minimum Essential Medium (EMEM) 
containing 10% fetal bovine serum (FBS). All cells were 
maintained at 37
0
 C, 5% CO2, 95% air and 100% relative 
humidity. 
MTT is a yellow water soluble tetrazolium salt. A 
mitochondrial enzyme in living cells, succinate-
dehydrogenase, cleaves the tetrazolium ring, converting the 
MTT to an insoluble purple formazan. Therefore, the 
amount of formazan produced is directly proportional to the 
number of viable cells. 
After 48h of incubation of cell lines treated with standard 
as well as the synthesized compounds, 15µl of MTT 
(5mg/ml) in phosphate buffered saline (PBS) was added to 
each well and incubated at 37
0
C for 4h. The medium with 
MTT was then flicked off and the formed formazan crystals 
were solubilized in 100µl of DMSO and then measured the 
absorbance at 570 nm using micro plate reader. The 
percentage cell inhibition was determined using the 
O
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following formula, 
% 𝑐𝑒𝑙𝑙 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =
100 − Abs sample
Abs control
𝑋 100 
 Nonlinear regression graph was plotted between % Cell 
inhibition and Log10 concentration and IC50 was determined 
using Graph Pad Prism software.
10
 
RESULTS AND DISCUSSION:  
Table 2: Lipinski rule analysis of some derivatives by Molinspiration 
Compound code 
 
milogP 
 
MW 
 
nON 
 
nOHNH 
 
nrotb 
 
nviolation 
 
BCH-b1 1.937 307.265 7 1 1 0 
BCH-b2 2.158 321.292 7 1 1 0 
BCH-a1 2.205 311.297 7 2 4 0 
BCH-a2 2.427 325.324 7 2 4 0 
 
Table 3: Docking Score for some derivatives against Tyrosine kinase 
Compound Code Tyrosine kinase 
 Energy Score 
(kcal/mol) 
Best Pose 
 
BCH-b1 -9.0856 98 
BCH-b2 -9.5872 99 
BCH-a1 -10.0721 95 
BCH-a2 -10.6572 69 
 
Table 4: Preliminary characterizations of newly synthesized compounds 
Compound 
Code 
Molecular 
formula 
Molecular 
weight 
Melting 
point (˚c ) 
Percentage 
Yield (%) 
Rf value 
 
BCH-b1 C16H9N3O4 307.265 220 60 0.78 
BCH-b2 C17H11N3O4 321.292 221 58 0.82 
BCH-a1 C16H13N3O4 311.297 220 61 0.70 
BCH-a2 C17H15N3O4 325.324 228 60 0.73 
 
Table 5: spectral value of synthesized compounds 
 
Pharmacological screening 
All tested compound show significant cytotoxicity towards human breast cell line. Among them BCH-a2 exhibit 
comparatively good activity.  
compounds Mass value IR Spectra 
1
HNMR 
BCH-a1 311 3215(O-H str of phenolic OH), 
1708(C=O str of amide), 1630(C=N 
str of benzoxazole), 1257(C-O-C). 
1.83(s, 3H of OCH3), 6.45-6.49(m, 3H ArH of 
hydroxyl anisole),7.02(s, 1H of CH), 6.56(s, 1H, 
Phenolic OH, D2O Exchangeable), 7.04-7.25(m, 4H, 
ArH of benzoxazole), 9.05(s, 1H, NH, D2O 
Exchangeable). 
BCH-a2 326 3470(N-H str of amide), 3275(O-H 
str of phenolic OH), 1708(C=O str 
of amide), 1630(C=N str of 
benzoxazole), 1225(C-O-C). 
2.30(s, 3H of CH3), 3.8(3H of OCH3)7.02-7.04(m, 3H 
ArH of hydroxyl anisole), 7.05(s, 1H of CH),7.26(s, 
1H, Phenolic OH, D2O Exchangeable), 7.79-7.82(m, 
3H, ArH of benzoxazole), 9.77(s, 1H, NH, D2O 
Exchangeable). 
BCH-b2 322 3271(N-H str of Phthalazinone), 
1713(C=O str of amide), 1226(C-O-
C str of benzoxazole). 
2.29(s, 3H CH3 of benzoxazole), 6.5-7.76(m, 4H ArH 
of phthalazine), 7.81-8.04(m, 3H, ArH of 
benzoxazole), 9.79(s, 1H, NH, Phthalazinone, D2O 
Exchangeable). 
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Table 6: IC50 values of tested compounds on MCF-7 
 
 
Anticancer activity of BCH-a2 on MCF-7 cell line 
                         
Figure 1: Showing Anticancer activity of BCH-a2 on MCF-7 cell line 
CONCLUSION: 
The preliminary insilico screening of various analogues 
was performed to assess the drug like properties using 
Molinspiration software. Drug likeness properties and bio 
activity of the proposed analogues were studied and all the 
compounds obeyed Lipinski rule of five were selected for 
further studies. Docking score of derivatives find out using 
Argus lab software and depending on good docking scores 
compound were selected for wet lab synthesis and further 
pharmacological screening. The prepared compounds 
were characterized using FTIR, 
1
HNMR and MASS spec-
tral analysis.    
Cytotoxicity studies were carried out by MTT assay. The 
values obtained were plotted against percentage cell 
inhibition and concentration gives a nonlinear graph which 
result in the IC50 values of each compound.  All tested 
compound show significant cytotoxicity towards human 
breast cell line. Among them BCH-a2 exibit 
comparatively good activity.  
ACKNOWLEDGEMENT: 
The author is thankful to the management of Devaki 
Amma Memorial College of Pharmacy, Malappuram for 
providing the facilities to carry out this research work.
 
REFERENCES: 
1. Priyanka L, B P  Nagori, Nikhil B, Anju G, S Gupta,Nisha S. 
Benzoxazole  The molecule of diverse biological activities. J. 
Chem. Pharm. Res 2011; 3(3):302-311. 
2.  Shrivastava.B, Vandana Sharma,Priyanka 
Lokwani,Benzoxazole:the nucleus of divers biological activities, 
Pharmacologyonline  2011;236-245.  
3. Mohamed A. Abdelgawada, Amany Belalb and Osama M. Ah-
medc. Synthesis, molecular docking studies and cytotoxic screen-
ing of certain novel thiazolidinone derivatives substituted with 
benzothiazole or benzoxazole, Journal of Chemical and Pharma-
ceutical Research 2013; 5(2):318-327. 
4. Sunila T. Patil1, Parloop A. Bhatt, Synthesis and pharmacological 
screening of some N` [substituted sulfonyl]-1, 3-benzoxazole-5-
carbohydrazides as an antiInflammatory agents, World Journal of 
pharmacy and Pharmaceutical Sciences 2013; 2(5): 2903-2914. 
5. Srinivas A., Vidyasagar J., Sarangapani M., Design, synthesis and 
biological evaluation of benzoxazole derivative as cyclooxyge-
nase-2 inhibitors, International Journal Of Pharmaceutical 
Sciences 2010; 2(1): 7-12.  
6. L P Singh, Viney C, Pooja C,Shailendra K S. Synthesis and anti-
microbial activity of some 2-phenyl-benzoxazole deriva-
tives.Scholars research library. Der pharma chemical 2010; 
2(4):206-212. 
7. P Christina, Ruby S, S Rajam, B R Venkatraman. Synthesis, cha-
racterization and biological evaluation of benzoxazole derivatives, 
Journal of Chemical and Pharmaceutical Research 2012; 
4(6):2988-2993. 
8. Shilpa P S, Anny M, Jayakumar T, S Chand, Cici M.In-silico 
design,synthesis and biological evaluation of N’-[(e)-(4-hydroxy-
3-methoxy phenyl)methylidene]-2-methyl-1,3-benzoxazole-5-
carbohydride  Asian journal of pharmaceutical and health 
sciences 2013; 3(1):661-676. 
9. Nadeem Siddiqui, M. Sarafroz, M. Mumtaz Alam., Synthesis, 
Anticonvulsant and Neurotoxicity Evaluation Of 5-
Carbomethoxybenzoxazole Derivatives, Acta Poloniae Pharma-
ceutica - Drug Research 2008; 65:449-455. 
10. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., 
Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., 
Gray-Goodrich, M., Campbell, H., Mayo, J., Boyd. Feasibility of 
high flux anticancer drug screen using a diverse panel of cultured 
human tumour cell lines. Journal of the National Cancer Institute 
1991; 83, 757-766. 
 
Compound 
Code 
% Cell Inhibition IC50 Value 
0.1µM 1µM 10µM 50µM 100µM 
BCH-b2 1.4845 3.7425 12.4514 39.7542 54.9826 80 
BCH-a1 0.9523 1.4285 8.9523 46.4255 63.7142 52 
BCH-a2 1.0481 7.1694 18.2081 53.2712 69.3126 47 
